University Minnesota, Dow Chemical findings help drugs work better
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

University of Minnesota, Dow Chemical findings help drugs work better

11:30 AM, 3rd November 2016
New method help oral medications dissolve in the body and be absorbed into the bloodstream, faster and more efficiently.
New method help oral medications dissolve in the body and be absorbed into the bloodstream, faster and more efficiently.

MINNEAPOLIS/MIDLAND, US: A group of researchers from the University of Minnesota (UMn) and The Dow Chemical Company have found a new method for modifying ingredients that help oral medications dissolve in the body and be absorbed into the bloodstream. The materials discovered could allow life-saving drugs to work faster and more efficiently.

They have filed a patent on the discovery that may also lower the cost to produce new medications.

The study is published online in the journal ACS Central Science.

One of the major challenges for pharmaceutical companies when evolving oral medications is to ensure that the body will fully absorb the drug molecules. Many therapeutic structures do not easily dissolve on the molecular level, which means they are less effective. In that case, the dose must be increased for patients, which may increase side effects.

“A method to clarify the differences in solubility of medicines is to consider how sugar easily dissolves in water and is rapidly absorbed by your digestive system, whereas sand doesn’t dissolve in water and if swallowed, would pass right through the digestive system,” said Theresa Reineke, a chemistry professor in the UMn college of science and engineering and lead researcher on the study.

Drug companies add substances, called excipients, to help the medicines dissolve in the stomach and intestinal fluid, but there have been few improvements in recent years to this decades-old technology. The process outlined in the study is a major breakthrough that revolutionises the process of making drug structures more soluble in the body so that they are better absorbed.

Funded by Dow, researchers examined two medications—phenytoin, an anti-seizure drug, and nilutamide, a drug used to treat advanced-stage prostate cancer. The team used automated equipment at Dow to synthesise long-chain molecules. Their efficiency as excipients with these drugs was then tested with facilities at the University of Minnesota, including the characterization facility located in the University’s college of science and engineering.

One particular excipient discovered by this research allowed these insoluble drugs to fully dissolve in simulated intestinal fluid in a test tube. When they tested phenytoin with the new excipient in rat models, it promoted drug absorption three times better than the previous formulation.

“While we were pleased with the results with these specific drugs, the most important thing is that we have developed a high-throughput methodology for excipient development that could be used by many companies to create other life-saving medicines,” Reineke said.

“It takes about $1 billion dollars and 10 to 15 years for a pharmaceutical company to develop a new drug, but then they sometimes find marketable formulations are limited by solubility,” said Steven Guillaudeu, a lead R&D manager at Dow and co-author of the study. “The methodology our team has created could help drug companies advance their pipeline compounds by using a better method to improve solubility and therefore bioavailability. The approach could have a major impact on the multibillion-dollar industry.”

The research discovery is one result of a five-year collaboration between Dow and the University of Minnesota for research partnerships to develop new chemical solutions, improve research facilities, and train the next generation of scientists.

“This discovery is a perfect example of what can happen when industry and academia come together,” said Frank Bates, a regent’s professor in the university’s department of chemical engineering and materials science and co-author of the study. “This research has yielded something that could have a huge effect on human health and lower the cost of medications.”

Other researchers include current and former University of Minnesota students and post-doctoral researchers Jeffrey Ting (lead author), Swapnil Tale, Anatolii Purchel, Seamus Jones, Lakmini Widanapathirana, Zachary Tolstyka and former Dow researcher Li Guo.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

IFF appoints Fluor’s vice president as its new CHRO

NEW YORK, US: International Flavors & Fragrances Inc (IFF) has appointed Susana Suarez-Gonzalez as its new executive vice president (EVP) and chie ...

Read more
Clariant increases mining footprint with new acquisitions, expansions

HOUSTON, US: Clariant International Ltd expands its mining solutions business and enhances its product portfolio, customer base and technical expertis ...

Read more
BASF, University of California to advance micro-encapsulation technology

FLORHAM PARK/DAVIS, US: BASF Corporation and University of California, Davis (UC Davis) entered into a cooperative research agreement to study a paten ...

Read more
Solvay begins production of highly dispersible silica in South Korea

BRUSSELS, BELGIUM: Solvay SA begins the production of highly dispersible silica (HDS) at its new state-of-the-art plant in Gunsan, South Korea, meetin ...

Read more
Shell, CNOOC JV gets approval to build several petrochemical facilities in China

BEIJING, CHINA: Shell Nanhai BV (Shell) and China National Offshore Oil Corporation’s (CNOOC) 50:50 joint venture has officially accepted owners ...

Read more
Fluor bags EPC contract for oxygen train project in South Africa

IRVING, US/JOHANNESBURG, SOUTH AFRICA: Fluor Corporation has been awarded an engineering, procurement and construction (EPC) contract by Sasol Group T ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X